300 related articles for article (PubMed ID: 17101326)
1. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer.
Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K
Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326
[TBL] [Abstract][Full Text] [Related]
2. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
[TBL] [Abstract][Full Text] [Related]
3. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.
Yashiro M; Shinto O; Nakamura K; Tendo M; Matsuoka T; Matsuzaki T; Kaizaki R; Miwa A; Hirakawa K
Int J Cancer; 2010 Feb; 126(4):1004-16. PubMed ID: 19621385
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer.
Matsuzaki T; Yashiro M; Kaizaki R; Yasuda K; Doi Y; Sawada T; Ohira M; Hirakawa K
Cancer Sci; 2009 Dec; 100(12):2402-10. PubMed ID: 19764996
[TBL] [Abstract][Full Text] [Related]
6. Combination effect of a TGF-beta receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Cancer Sci; 2010 Aug; 101(8):1846-52. PubMed ID: 20518790
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling.
Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.
Hippo Y; Yashiro M; Ishii M; Taniguchi H; Tsutsumi S; Hirakawa K; Kodama T; Aburatani H
Cancer Res; 2001 Feb; 61(3):889-95. PubMed ID: 11221876
[TBL] [Abstract][Full Text] [Related]
9. A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells.
Tendo M; Yashiro M; Nakazawa K; Yamada N; Sawada T; Ohira M; Hirakawa K
Cancer Lett; 2006 Dec; 244(2):247-51. PubMed ID: 16448745
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
Tendo M; Yashiro M; Nakazawa K; Yamada N; Hirakawa K
Cancer Sci; 2005 Jul; 96(7):451-5. PubMed ID: 16053517
[TBL] [Abstract][Full Text] [Related]
11. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
[TBL] [Abstract][Full Text] [Related]
12. A novel angiogenesis inhibitor, Ki23057, is useful for preventing the progression of colon cancer and the spreading of cancer cells to the liver.
Sakurai K; Yamada N; Yashiro M; Matsuzaki T; Komatsu M; Ohira M; Miwa A; Hirakawa K
Eur J Cancer; 2007 Nov; 43(17):2612-20. PubMed ID: 17949968
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Clin Exp Metastasis; 1996 Jan; 14(1):43-54. PubMed ID: 8521616
[TBL] [Abstract][Full Text] [Related]
14. Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer.
Yashiro M; Chung YS; Sowa M
Anticancer Res; 1997; 17(2A):895-900. PubMed ID: 9137424
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a new scirrhous gastric carcinoma cell line with microsatellite instability.
Koyama T; Yashiro M; Matsuoka T; Sunami T; Ohira M; Hirakawa K
Oncol Rep; 2004 Aug; 12(2):317-21. PubMed ID: 15254696
[TBL] [Abstract][Full Text] [Related]
17. FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival.
Kunii K; Davis L; Gorenstein J; Hatch H; Yashiro M; Di Bacco A; Elbi C; Lutterbach B
Cancer Res; 2008 Apr; 68(7):2340-8. PubMed ID: 18381441
[TBL] [Abstract][Full Text] [Related]
18. A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells.
Qiu H; Yashiro M; Zhang X; Miwa A; Hirakawa K
Cancer Lett; 2011 Aug; 307(1):47-52. PubMed ID: 21482024
[TBL] [Abstract][Full Text] [Related]
19. Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer.
Yanagihara K; Takigahira M; Tanaka H; Komatsu T; Fukumoto H; Koizumi F; Nishio K; Ochiya T; Ino Y; Hirohashi S
Cancer Sci; 2005 Jun; 96(6):323-32. PubMed ID: 15958054
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma.
Nakazawa K; Yashiro M; Hirakawa K
Cancer Res; 2003 Dec; 63(24):8848-52. PubMed ID: 14695201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]